Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
Gianluigi Savarese, MD
Early intervention & long-term success: Navigating hyperkalemia in cardiorenal disease
Aaron Wong, MD
James Burton, DM, FRCP
Clara Bonanad Lozano, MD, PhD
Evidence-based novel therapies in HCM
Michelle Michels, MD
Optimal pharmacological management of HCM by clinical manifestations
Pablo Garcia-Pavia, MD, PhD
Recognizing and diagnosing heart failure in patients with HCM
Aleš Linhart, MD, PhD
Staging therapy in hypertrophic cardiomyopathy patients with heart failure: New insights
What to do if potassium levels increase in HF?
Mikhail Kosiborod, MD
Continuing foundational therapy in symptomatic HF: the key role of RAASi-based therapy
Shelley Zieroth, MD
Practical experience and model for optimizing RAASi-based therapy in HF
Breaking barriers in guideline-based RAASi therapy: Solving issues with hyperkalemia
Recognizing HCM and HF: making the diagnosis
Mariana Brandão, MD
Hypertrophic cardiomyopathy & heart failure: exploring new options
Rudolf de Boer, MD, PhD
Iacopo Olivotto, MD
HCM and heart failure: is your patient at risk?
Managing patients with HCM and HF: what’s new in the therapeutic landscape?
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.